β-Catenin (CTNNB1); B cell lymphoma 2 (BCL-2; BCL2); AXIN1; casein kinase 1α (CSNK1A1; CKI-α) BriefCommunication Pages: 1057 - 1057
Heat shock protein 90 (Hsp90); heat shock 90 kDa protein β1 (Hsp90B1; GP96; GRP94) BriefCommunication Pages: 1058 - 1058
Neuronal precursor cell expressed developmentally downregulated 8 (NEDD8); cullin 4A (CUL4A) BriefCommunication Pages: 1062 - 1062
Epidermal growth factor receptor (EGFR); HER2 (EGFR2; ErbB2; neu) BriefCommunication Pages: 1063 - 1063
IL-6 signal transducer (IL-6ST; gp130; CD130); IL-27; IL-27 receptor-α (IL27RA) BriefCommunication Pages: 1065 - 1065
NMDA receptor NR1 subtype (GRIN1; NR1); GRIN2B (NR2B); GABAA receptor α1 (GABRA1); GABAA receptor β3 (GABRB3) BriefCommunication Pages: 1068 - 1068
Low-copy piggyBac (PB) mutagenesis screening to identify mutated genes that drive cancer BriefCommunication Pages: 1073 - 1073
Doxycycline-inducible adipocyte labeling system for in vivo adipogenesis monitoring BriefCommunication Pages: 1075 - 1075
Interferon regulatory factor 4 ( Irf4 )-deficient mouse models of chronic lymphocytic leukemia (CLL) BriefCommunication Pages: 1076 - 1076
Mouse model of phosphoinositide 3-kinase catalytic subunit α-polypeptide ( PIK3CA ; p110α )-mutant, HER2 (EGFR2; ErbB2; neu)+ breast cancer BriefCommunication Pages: 1077 - 1077
Safety mechanism assisted by the repressor of tetracycline (SMART) oncolytic Vaccinia vaccines BriefCommunication Pages: 1078 - 1078
Locus-specific control of histone modification using transcription activator–like (TAL) effector repeat fusion proteins BriefCommunication Pages: 1079 - 1079
Mice overexpressing kidney injury molecule 1 ( Kim-1 ) to model chronic kidney disease (CKD) BriefCommunication Pages: 1080 - 1080
Combined microscopy system to image tumors during tissue-conserving surgery BriefCommunication Pages: 1081 - 1081
Secondary Cherenkov–induced fluorescence imaging (SCIFI) to detect markers of disease activity BriefCommunication Pages: 1082 - 1082